Mereo BioPharma Group plc
MREO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,024 | -$14,616 | -$12,887 | -$7,046 |
| Dep. & Amort. | -$11 | $298 | $270 | $274 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,065 | $2,278 | $1,515 |
| Change in WC | $636 | -$843 | -$514 | $857 |
| Other Non-Cash | -$910 | $5,445 | $2,524 | -$5,020 |
| Operating Cash Flow | -$7,309 | -$7,651 | -$8,329 | -$9,420 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$20 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $300 | $0 | -$300 | $0 |
| Investing Cash Flow | $300 | $0 | -$320 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$134 | $422 | -$40 |
| Financing Cash Flow | $0 | -$134 | $422 | -$40 |
| Forex Effect | -$418 | $1,427 | $908 | -$1,260 |
| Net Chg. in Cash | -$7,427 | -$6,358 | -$7,319 | -$10,720 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56,125 | $62,483 | $69,802 | $80,522 |
| End Cash | $48,698 | $56,125 | $62,483 | $69,802 |
| Free Cash Flow | -$7,309 | -$7,651 | -$8,649 | -$9,420 |